I can see patient lawyers licking their lips for an eazy win against doctors percribing Lovaza. Once news media gets wiff, they would ask the FDA, why are you allowing the poisioning of Americans?
Raf I still remember when Lovaza was being marketed - they never once mentioned that they increased LDL by 49% - I remember reading about it in the fine print of the prescribing reference. Ever since then I have wondered how the FDA could have let them be marketed without checking on the relative risk of inducing cardiac disease - wow this sounds like a class action waiting to happen ...
Why would GSK not jump on AMRN and the EPA only science and turn it into a world class multi-billion $ drug to replace lost revenue from the fall of Lovasa?